SCHWARTZ MARK W. 4
4 · Galena Biopharma, Inc. · Filed Jul 11, 2012
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Common Stock, par value $0.0001
2012-06-15+89,322→ 439,907 total - Other
Common Stock, par value $0.0001
2012-07-10$0.40/sh+21,902$8,750→ 461,809 total
Footnotes (2)
- [F1]The shares shown were issued in escrow on February 15, 2012 for the account of the reporting person at a value of $0.76 per share in payment of contingent value rights held by the reporting person, subject to release of the shares from escrow upon approval of the issuance by the stockholders of Galena Biopharma, Inc. The Galena stockholders approved the issuance on June 15, 2012.
- [F2]Pursuant to the Issuer's Employee Stock Purchase Plan.